- Home
- ETON vs MLAC Comparison
ETON vs MLAC Comparison
Compare ETON & MLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- MLAC
- Stock Information
- Founded
- ETON 2017
- MLAC 2024
- Country
- ETON United States
- MLAC United States
- Employees
- ETON N/A
- MLAC N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- MLAC
- Sector
- ETON Health Care
- MLAC
- Exchange
- ETON Nasdaq
- MLAC NYSE
- Market Cap
- ETON 428.5M
- MLAC 314.4M
- IPO Year
- ETON 2018
- MLAC 2024
- Fundamental
- Price
- ETON $17.33
- MLAC $10.18
- Analyst Decision
- ETON Strong Buy
- MLAC
- Analyst Count
- ETON 3
- MLAC 0
- Target Price
- ETON $27.67
- MLAC N/A
- AVG Volume (30 Days)
- ETON 221.4K
- MLAC 94.6K
- Earning Date
- ETON 05-13-2025
- MLAC 01-01-0001
- Dividend Yield
- ETON N/A
- MLAC N/A
- EPS Growth
- ETON N/A
- MLAC N/A
- EPS
- ETON N/A
- MLAC N/A
- Revenue
- ETON $39,011,000.00
- MLAC N/A
- Revenue This Year
- ETON $92.33
- MLAC N/A
- Revenue Next Year
- ETON $52.62
- MLAC N/A
- P/E Ratio
- ETON N/A
- MLAC $415.34
- Revenue Growth
- ETON 23.29
- MLAC N/A
- 52 Week Low
- ETON $3.18
- MLAC $9.94
- 52 Week High
- ETON $18.41
- MLAC $10.17
- Technical
- Relative Strength Index (RSI)
- ETON 68.29
- MLAC N/A
- Support Level
- ETON $16.43
- MLAC N/A
- Resistance Level
- ETON $17.49
- MLAC N/A
- Average True Range (ATR)
- ETON 0.88
- MLAC 0.00
- MACD
- ETON 0.19
- MLAC 0.00
- Stochastic Oscillator
- ETON 92.78
- MLAC 0.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About MLAC MOUNTAIN LAKE ACQUISITION CORP
Mountain Lake Acquisition Corp is a blank check company.